These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4906138)
1. Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenics. Ananth JV; Ban TA; Lehmann HE; Bennett J Can Psychiatr Assoc J; 1970 Feb; 15(1):15-20. PubMed ID: 4906138 [No Abstract] [Full Text] [Related]
2. Potentiation of therapeutic effects of nicotinic acid by pyridoxine in chronic schizophrenics. Ananth JV; Ban TA; Lehmann HE Can Psychiatr Assoc J; 1973 Oct; 18(5):377-83. PubMed ID: 4147710 [No Abstract] [Full Text] [Related]
3. Nicotinic acid and catechol-O-methyl-transferase activity in schizophrenia. Ban TA; Lehmann HE; Klingner A Int J Clin Pharmacol; 1973 Feb; 7(1):44-7. PubMed ID: 4699383 [No Abstract] [Full Text] [Related]
4. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia. Vallely JF; Lovegrove TD; Hobbs GE Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335 [No Abstract] [Full Text] [Related]
5. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study. Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601 [No Abstract] [Full Text] [Related]
7. Nicotinic acid in the treatment of schizophrenias. Canadian Mental Health Association collaborative study: progress report II. Ban TA; Lehmann HE Can Psychiatr Assoc J; 1975 Mar; 20(2):103-12. PubMed ID: 1100217 [No Abstract] [Full Text] [Related]
8. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study. Deutsch M; Ananth JV; Ban TA Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260 [No Abstract] [Full Text] [Related]
9. A controlled study of lithium vs. chlorpromazine in acute schizophrenics. Shopsin B; Kim SS; Gershon S Br J Psychiatry; 1971 Oct; 119(551):435-40. PubMed ID: 4942959 [No Abstract] [Full Text] [Related]
11. Two pilot studies of AHR-1680 in chronic schizophrenic patients. Sugerman AA; Herrmann J; O'Hara M; Simpson GM; Angus JW; Deutsch L J Clin Pharmacol J New Drugs; 1969; 9(3):183-6. PubMed ID: 4892454 [No Abstract] [Full Text] [Related]
12. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia. Petrie WM; Ban TA; Ananth JV Int Pharmacopsychiatry; 1981; 16(4):245-50. PubMed ID: 7040274 [TBL] [Abstract][Full Text] [Related]
13. Nicotinic acid in the treatment of schizophrenia. Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841 [No Abstract] [Full Text] [Related]
14. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review. Wittkopp TA; Abuzzahab FS Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727 [No Abstract] [Full Text] [Related]
15. Transmethylation hypothesis of schizophrenia: methionine and nicotinic acid. Nestoros JN; Ban TA; Lehmann HE Int Pharmacopsychiatry; 1977; 12(4):215-46. PubMed ID: 338534 [TBL] [Abstract][Full Text] [Related]
17. A search for responders to niacin supplementation. Wittenborn JR Arch Gen Psychiatry; 1974 Oct; 31(4):547-52. PubMed ID: 4607587 [No Abstract] [Full Text] [Related]
18. Niacin in the long-term treatment of schizophrenia. Wittenborn JR; Weber ES; Brown M Arch Gen Psychiatry; 1973 Mar; 28(3):308-15. PubMed ID: 4569673 [No Abstract] [Full Text] [Related]
19. Negative findings with nicotinic acid in the treatment of schizophrenias. Ban TA Int Pharmacopsychiatry; 1974; 9(3):172-87. PubMed ID: 4430570 [No Abstract] [Full Text] [Related]
20. Treatment of resistant schizophrenics with extreme high dosage fluphenazine hydrochloride. Itil T; Keskiner A; Heinemann L; Han T; Gannon P; Hsu W Psychosomatics; 1970; 11(5):456-63. PubMed ID: 4919176 [No Abstract] [Full Text] [Related] [Next] [New Search]